LA
TMO icon

LBP AM’s Thermo Fisher Scientific TMO Stock Holding History

LBP AM’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.8M Sell
167,179
-44,302
-21% -$21.3M 0.84% 23
2026
Q1 		$104M Sell
211,481
-2,819
-1% -$1.53M 1.42% 14
2025
Q4 		$124M Sell
214,300
-56,190
-21% -$31.8M 1.44% 13
2025
Q3 		$131M Buy
270,490
+9,452
+4% +$4.4M 1.61% 12
2025
Q2 		$106M Buy
261,038
+30,837
+13% +$12.9M 1.49% 12
2025
Q1 		$115M Buy
230,201
+69,507
+43% +$37.6M 1.77% 9
2024
Q4 		$83.6M Buy
160,694
+28,585
+22% +$15.7M 1.13% 16
2024
Q3 		$81.7M Buy
132,109
+130,499
+8,106% +$77.2M 1.23% 16
2024
Q2 		$890K Sell
1,610
-31
-2% -$17.8K 0.04% 285
2024
Q1 		$954K Sell
1,641
-64,443
-98% -$36.2M 0.04% 242
2023
Q4 		$35.1M Sell
66,084
-15,507
-19% -$7.51M 0.77% 29
2023
Q3 		$41.3M Sell
81,591
-9,605
-11% -$5.12M 0.92% 21
2023
Q2 		$47.6M Sell
91,196
-2,520
-3% -$1.36M 1.13% 16
2023
Q1 		$54M Buy
93,716
+3,300
+4% +$1.86M 1.37% 9
2022
Q4 		$49.8M Buy
+90,416
New +$47.9M 1.42% 9

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LBP AM's TMO Position: Q2 2026 in Review

LBP AM reduced its Thermo Fisher Scientific (TMO) stake by 21% in Q2 2026, selling an estimated $21.3M and leaving 167,179 shares worth $83.8M. The position accounts for 0.84% of the portfolio, ranked #23.

LBP AM first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $131M in Q3 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • LBP AM held 167,179 shares of Thermo Fisher Scientific worth $83.8M as of Q2 2026.
  • LBP AM sold 44,302 Thermo Fisher Scientific shares in Q2 2026, an estimated $21.3M.
  • Thermo Fisher Scientific made up 0.84% of LBP AM's portfolio in Q2 2026, its #23 holding.
  • LBP AM first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • LBP AM's Thermo Fisher Scientific position peaked at $131M in Q3 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on LBP AM's 13F filing for Q2 2026, filed 24 Jul 2026.